Red List:Official warnings and scam reports, with sourcesCheck a link
Check a link
Regulatory warningOfficial actionRegulatory note

Instituto Alma Viva Ltda. (Allandiol / Biocase)

ANVISA banned the sale and advertising of two Allandiol CBD products for lacking registration or authorization (May 2026)

This entry is about Brazil — not the country you picked in the header.

According to Agência Nacional de Vigilância Sanitária (ANVISA), May 11, 2026 · Read the source

Where
Brazil
First reported
Last checked

Summary

On 11 May 2026 Brazil's health regulator ANVISA announced Resolution 1.914/2026, prohibiting the sale and advertising of Allandiol Forte Black 1:1 and Allandiol Full Spectrum 300 mg, cannabis-based products under the Biocase/Allandiol brands attributed to Instituto Alma Viva Ltda. According to ANVISA, the products had no sanitary registration or authorization, both mandatory for cannabis products in Brazil, and the company had no Operating Authorization (AFE) to manufacture or market cannabis derivatives. ANVISA said it found the products offered on the company's website and Instagram profile with claimed therapeutic benefits. The measure covers any person or company that advertises, sells or promotes them, in any channel.

What the source found

  • ANVISA said the two Allandiol products had no sanitary registration or authorization.
  • ANVISA said Instituto Alma Viva Ltda. had no Operating Authorization (AFE) to manufacture or sell cannabis derivatives.
  • The products were offered on the company's website and Instagram with claimed therapeutic benefits, according to ANVISA.
  • Resolution 1.914/2026 bans their sale and advertising by anyone, in all channels.

Products named

  • Allandiol Forte Black 1:1
  • Allandiol Full Spectrum 300 mg

Timeline

  1. ANVISA announces Resolution 1.914/2026 banning sale and advertising

Sources

  1. Regulator

    Agência Nacional de Vigilância Sanitária (ANVISA) · May 11, 2026

    Anvisa proíbe produtos à base de cannabis

Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.

Status notes

Domain and Instagram handle not given in ANVISA's note, so not added. The Diário Oficial da União text of Resolution 1.914/2026 was not opened; the resolution type (RE) is therefore not stated.

Comments

No comments yet.

Comments are read by a moderator before they’re published.

The full Red List
Regulatory warningOfficial action

sacmedicinatural.wixsite.com/cbd-medicinatural-1 (cannabis products site)

sacmedicinatural[.]wixsite[.]com/cbd-medicinatural-1

Anvisa banned promotion of unregistered cannabis products advertised on a Wix site and social media

Brazil · Sep 21, 2026
Regulatory warningOfficial action

Associação Canábica Nordeste (Acanne)

Acanne

Anvisa prohibited all cannabis products of Acanne, citing no valid operating authorization

Brazil · Aug 6, 2026
Regulatory warningOfficial action

Vitanabis Intermediação e Serviços Ltda.

Vitanabis

Anvisa prohibited all cannabis derivatives sold by Vitanabis and advertised online

Brazil · Aug 3, 2026
Report a seller

Tell us what happened

Every report is read by a person. You don’t need to prove anything, and we never publish your name.

What happens next
  • A moderator reads your report and checks the link against the Red List and our seller records.
  • We look for an authoritative source — a regulator, court, police or consumer-protection finding.
  • When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.
Report a seller

Self-check · 2 minutes · private

Is cannabis becoming a problem for you?

Eight questions from CUDIT-R, a screening test used by clinicians. Your answers never leave this page.